26 /100
MEDIUM RISK
Score updated Jul 14, 2026

IXHL — Incannex Healthcare Inc. Dilution Risk Tracker

Track IXHL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IXHL — Get alerts when the score changes →

As of July 14, 2026, Incannex Healthcare Inc. (IXHL) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Incannex Healthcare Inc. has a market capitalization of $40.08M, 11.96M shares outstanding. Key dilution vectors include ATM program capacity of $150.00M, 453.7K outstanding warrants, approximately 71 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
13%
💰 Capital Raise 18%
• Active ATM program with $150M remaining capacity
🔁 Convertible Conversion 15%
• Convertible debt present: 6.9% potential dilution
🔔 Track IXHL — Get forecast alerts →

💹 Market Data

Market Cap$40.08M
Shares Outstanding11.96M
Float9.87M
Cash$74.45M
Debt$3.78M
Short InterestN/A

🏛 Institutional Holdings

12.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track IXHL for full holder detail →

📉 Short Interest

Short Interest509.1K
Days to Cover1.9
% of Float5.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Jun 30, 2025
8-K 8K EVENT Mar 12, 2026
8-K 8K EVENT Mar 12, 2026
424B5 ATM Mar 12, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for IXHL Shareholders

Incannex Healthcare Inc. (IXHL) has a DilutionScore of 26/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

IXHL has an active ATM (at-the-market) program with $150.0M remaining capacity. ATM programs allow companies to sell shares continuously into the open market through a broker-dealer — without announcing a secondary offering. This creates a silent but steady source of share dilution that shows up in quarterly share count increases rather than a discrete offering event. DilutionWatch tracks 453,749 outstanding warrants for IXHL. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for IXHL in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for IXHL alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

How ATM Offerings Work → Warrants Explained →
Track IXHL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IXHL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for IXHL
📊 IXHL FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 IXHL Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.